STTKNasdaqPharmaceutical PreparationsFiscal year ends December 31
Shattuck Labs, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026
$5.37−0.05 (-0.92%)
Close on Oct 19, 2026
- Market cap
- $696.91M
- P/E (TTM)
- –
- Dividend yield
- –
Shattuck Labs statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Pharmaceutical Preparations companies for comparison
Valuation
| Measure | Shattuck Labs | Industry median |
|---|---|---|
| Market Cap | $538.95M | $197.05M |
| Enterprise Value | $330.65M | $106.56M |
| PS Ratio | 538.95 | 3.93 |
| PB Ratio | 2.55 | 2.14 |
| P/TBV Ratio | 2.55 | 2.46 |
Enterprise value
| Measure | Shattuck Labs | Industry median |
|---|---|---|
| EV / Sales | 330.65 | 2.69 |
Income (trailing twelve months)
| Measure | Shattuck Labs | Industry median |
|---|---|---|
| Revenue | $1.00M | $57.94M |
| Operating Income | -$55.79M | -$21.44M |
| Net Income | -$52.57M | -$22.46M |
| EBITDA | -$55.79M | -$16.91M |
| EPS (Diluted) | -$0.51 | -$0.83 |
Margins
| Measure | Shattuck Labs | Industry median |
|---|---|---|
| Operating Margin | -5578.7% | -44.5% |
| Profit Margin | -5256.8% | -39.2% |
| EBITDA Margin | -5578.7% | -31.3% |
Returns
| Measure | Shattuck Labs | Industry median |
|---|---|---|
| Return on Equity (ROE) | -39.2% | -53.1% |
| Return on Assets (ROA) | -36.9% | -41.0% |
| Return on Invested Capital (ROIC) | -942.2% | -32.0% |
| Return on Capital Employed (ROCE) | -26.2% | -37.8% |
Growth
| Measure | Shattuck Labs | Industry median |
|---|---|---|
| Revenue Growth (YoY) | -66.6% | 6.01% |
| Revenue Growth (3Y CAGR) | 15.3% | 2.25% |
| Revenue Growth (5Y CAGR) | -36.8% | 6.42% |
Balance sheet
| Measure | Shattuck Labs | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $208.30M | $62.42M |
| Net Cash (Debt) | $208.30M | $15.68M |
| Net Cash Per Share | $2.08 | $0.65 |
| Equity (Book Value) | $211.14M | $48.79M |
| Book Value Per Share | $2.10 | $1.36 |
| Tangible Book Value | $211.14M | $23.06M |
| Working Capital | $205.54M | $75.77M |
Financial position
| Measure | Shattuck Labs | Industry median |
|---|---|---|
| Current Ratio | 27.59 | 3.30 |
| Quick Ratio | 26.94 | 2.39 |
Cash flow (trailing twelve months)
| Measure | Shattuck Labs | Industry median |
|---|---|---|
| Operating Cash Flow | -$41.03M | -$12.35M |
Efficiency
| Measure | Shattuck Labs | Industry median |
|---|---|---|
| Asset Turnover | 0.01 | 0.38 |
| Revenue Per Employee | $25.00K | $398.96K |
| Profits Per Employee | -$1.31M | -$732.08K |
| Employee Count | 40 | 73 |
Dividends and yields
| Measure | Shattuck Labs | Industry median |
|---|---|---|
| Earnings Yield | -9.75% | -21.2% |
| Buyback Yield | -27.0% | -0.58% |
| Shareholder Yield | -27.0% | 0.00% |
Shares
| Measure | Shattuck Labs | Industry median |
|---|---|---|
| Shares Outstanding | 100,363,000 | 59,128,900 |
| Shares Change (YoY) | 105.4% | 11.1% |
| Shares Change (QoQ) | 33.3% | 0.54% |
| Float | 76,180,800 | 48,744,500 |
| Shares Held by Insiders | 24.1% | 11.8% |
| Shares Held by Institutions | 83.5% | 59.4% |
Scores
| Measure | Shattuck Labs | Industry median |
|---|---|---|
| Altman Z-Score | 31.30 | 0.10 |
| Piotroski F-Score | 4 | 4 |
Calculated by StockData from Shattuck Labs's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.